November 15, 2023
2 min watch
Save
VIDEO: Miebo provides new approach to dry eye disease
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, John D. Sheppard, MD, MMSc, discusses Miebo for the treatment of dry eye disease.
Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb), a semifluorinated alkane molecule, is indicated for patients with dry eye disease who have accompanying meibomian gland disease.
Miebo is “a very simple, elegant, water-free 11 µL microdroplet approach to dry eye disease,” Sheppard said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Sheppard reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.